MedTrace Logo

Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents

NCT01947296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 284

Last updated 2017-02-23

No results posted yet for this study

Summary

The purpose is to estimate evolution of patients treated by oral neoplastic agents, in term of early or unforeseen recourse to the hospital for adverse events.

Conditions

Sponsors & Collaborators

  • oncorif

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Jean-¨Pierre Lotz, Professor · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-02-29
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947296 on ClinicalTrials.gov